Novo Nordisk A/S (NVO) Q2 2024 Earnings Call Transcript

Novo Nordisk A/S (NVO) Q2 2024 Earnings Conference Call August 7, 2024 7:00 AM ET

Company Participants

Jacob Martin Wiborg Rode - Head of Investor Relations
Lars Fruergaard Jørgensen - Chief Executive Officer
Camilla Sylvest - Executive Vice President, Head of Commercial Strategy & Corporate Affairs
Doug Langa - Executive Vice President, Head of North America Operations
Martin Holst Lange - Executive Vice President, Head of Development
Karsten Munk Knudsen - Chief Financial Officer

Conference Call Participants

Emily Field - Barclays
Evan Seigerman - BMO Capital Markets
Sachin Jain - Bank of America
Richard Vosser - JPMorgan
Peter Verdult - Citigroup
James Quigley - Goldman Sachs
Emmanuel Papadakis - Deutsche Bank
Simon Baker - Redburn Atlantic
Mark Purcell - Morgan Stanley

Operator

Good day, and thank you for standing by. Welcome to the First Six Months of 2024 Novo Nordisk A/S Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your first speaker today, Jacob Rode, Head of Investor Relations. Please go ahead, sir.

Jacob Martin Wiborg Rode

Thank you. Welcome to this Nova Nordisk Earnings Call for the First Six Months of 2024. My name is Jacob Martin Wiborg Rode and I'm the Head of Investor Relations at Nova Nordisk. With me today, I have CEO of Novo Nordisk, Lars Fruergaard Jorgensen; Executive Vice President and Head of Commercial Strategy and Corporate Affairs, Camilla Sylvest; Executive Vice President and Head of North America Operations, Doug Langa; Executive Vice President and Head of Development, Martin Holst Lange; and finally, Chief Financial Officer, Karsten Munk Knudsen. All speakers will be available for the Q&A session.

Today's announcement and the slides for this call are available on our website, novonordisk.com. Please note that this call is being webcasted live